Related Experiment Video
Updated: May 5, 2026

15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
9.0K
An Ultra-rare Disease? Where Do We Go from Here?
1Advocacy for Neuroacanthocytosis Patients, London, United Kingdom.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|November 21, 2013
Summary
Families facing rare incurable disorders like chorea-acanthocytosis can establish non-profit organizations to fund crucial research. This approach addresses the lack of resources and information, driving scientific progress for rare diseases.
Area of Science:
- Neuroscience
- Rare Diseases
- Genetics
Background:
- Rare, incurable disorders impose significant burdens on patients and families.
- Limited information and resources exacerbate the challenges of managing rare diseases.
- Research into rare diseases is critically dependent on adequate funding.
Purpose of the Study:
- To share experiences of establishing a not-for-profit organization for rare disease research.
- To highlight the process of funding and facilitating research for chorea-acanthocytosis.
- To emphasize the role of personal relationships in advancing neuroacanthocytosis research.
Main Methods:
- Personal narrative of establishing a not-for-profit organization.
- Description of efforts to fund and facilitate research.
- Emphasis on building relationships with clinicians, scientists, and community members.
Main Results:
- Successful establishment of a not-for-profit organization dedicated to chorea-acanthocytosis research.
- Demonstrated a viable model for patient-driven research funding and facilitation.
- Significant progress in the field of neuroacanthocytosis research attributed to collaborative efforts.
Conclusions:
- Patient advocacy and the establishment of dedicated organizations can effectively drive research for rare diseases.
- Personal connections and community support are vital for overcoming research funding and resource challenges.
- This initiative provides a template for other families affected by rare, incurable disorders.
Related Concept Videos
Lethal Alleles
11.4K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
11.4K
Huntington Disease l: Introduction
166
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
166
Translation
133.7K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
133.7K
Translation
16.8K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
16.8K
Sex-linked Disorders
95.2K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
95.2K
Other Unique Bacteria
578
Magnetic bacteria exhibit a directed movement called magnetotaxis, driven by structures called magnetosomes. These magnetosomes consist of chains of magnetic particles made of either magnetite (Fe₃O₄) or greigite (Fe₃S₄) and are organized in a linear conformation by a protein scaffold within invaginations of the cell membrane. The bacteria align along the north–south magnetic field lines, much like a compass needle. They are typically microaerophilic or anaerobic...
578

